United States · What does TPG-Axon Capital invest in?
TPG-Axon Capital invests most often at Growth (100% of the rounds on record), in sectors such as Agriculture and Solar.
TPG-Axon Capital highlights
- 01
1 rounds on record
- 02
Mostly Growth: 100% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- AgricultureSolar
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2011
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
D"Dinakar "nmn" SinghFounding Partner & Chief Executive OfficeriForm ADV
JMJennifer Marie LevensChief Compliance OfficeriForm ADV
KGKoryn Gatta EstradaCo-Chief Executive OfficeriForm ADV
We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$527Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- AXON Capital LP
- SEC number
- CRD 158281
Funds on its Form ADV
2 private funds, $504M in gross assets · filed Mar 2024
- AXON Partners, L.P.Hedge201 investors$270M
- AXON International, L.P.Hedge247 investors$235M
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Merrimack PharmaceuticalsListedUndisclosedMar 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.